Search Results for “EU” – Page 370 – media

Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS

Sangamo Therapeutics, Inc. and Pfizer Inc. announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 gene.
- Source: Prnewswire
- 448
- January 9, 2018
ALS FTLD Market Views neurodegenerative disease
J&J signs 15 deals for new healthcare solutions

Johnson & Johnson (J&J) has signed 15 new partnerships to explore, develop and advance new medical devices, therapeutics and consumer health solutions.
- Source: Verdict Medical Devices
- 706
- January 9, 2018
AI cancer Company Insight Johnson & Johnson
Shire’s cytomegalovirus therapy wins ‘Breakthrough’ status

An experimental drug being developed by Shire to treat cytomegalovirus (CMV) infection has been given a boost in the US with a ‘Breakthrough Therapy Designation’.
- Source: pharmatimes
- 512
- January 8, 2018
Company Insight compromised immunity cytomegalovirus virus
Addex, Indivior Forge $335M Addiction Disorder Tie-Up

Indivior announced that Indivior UK Limited has entered into a strategic collaboration with Addex Pharma S.A., a wholly-owned subsidiary of Addex Therapeutics (SIX: ADXN) ("Addex"), in the field of GABAB positive allosteric modulators (PAMs). GABAB PAMs have demonstrated preclinical efficacy and tolerability in animal models for alcohol use disorder (AUD) and cocaine use disorder (CUD)1,2.
- Source: Biospace
- 421
- January 8, 2018
AUD CUD GABAB PAM Market Views
Pfizer, Arvinas Forge $830M Protein Degradation R&D Deal

Two months after expanding a licensing deal with Genentech, privately-held Arvinas LLC struck another lucrative deal with a major pharmaceutical company. Connecticut-based Arvinas inked a deal with Pfizer worth up to $830 million to develop small molecules that can degrade proteins.
- Source: Biospace
- 526
- January 8, 2018
Genentech Pfizer pharmaceutical company PROTAC small molecule therapeutics
Next-generation medical scanning

Researchers have developed a new way to magnetise molecules found naturally in the human body, paving the way for a new generation of low-cost magnetic resonance imaging (MRI) technology that would transform our ability to diagnose and treat diseases including cancer, diabetes and dementia.
- Source: ScienceDaily
- 522
- January 8, 2018
medical device MRI Researches
BioNTech raises $270M A round to fuel mRNA, CAR-T R&D

BioNTech has raised $270 million (€224 million). The series A round positions the German biotech to mount a multifront attack on cancer, spearheaded by mRNA therapies and supported by a clutch of other modalities including CAR-T cells.
- Source: fiercebiotech
- 644
- January 5, 2018
CAR-T therapy Company Insight mRNA Series
Precision editing of gut bacteria– Potential way to treat colitis

UT Southwestern Medical Center researchers have used precision editing of the bacterial populations in the gut to prevent or reduce the severity of inflammation in a mouse model of colitis.
- Source: sciencedaily
- 563
- January 5, 2018
colitis gut bacteria Researches
Innovative device helpful in hip replacement surgery

An innovative device for measuring the change of the femur position during hip replacement surgery has been built by scientists from Lodz University of Technology. Its use shortens the time of surgery and gives better chance that patients after surgery will not have problems with walking.
- Source: Science in Poland
- 857
- January 5, 2018
medical device medical device products Researches surgery
Sangamo partners with Pfizer to develop gene therapy for ALS

Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS
- Source: Reuters
- 502
- January 4, 2018
ALS Company Insight FDA Gene therapy Pfizer

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.